世界の女性用性的欲求低下障害(HSDD)治療薬市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV11926)
◆英語タイトル:Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV11926
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:98
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは女性用性的欲求低下障害(HSDD)治療薬の世界市場について調査・分析した資料です。種類別(BP-101、ブレメラノチド、塩酸ゲピロンER、PVT-011、その他)の市場規模、用途別(外来患者、入院患者)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別女性用性的欲求低下障害(HSDD)治療薬の競争状況、市場シェア
・世界の女性用性的欲求低下障害(HSDD)治療薬市場:種類別市場規模 2015年-2020年(BP-101、ブレメラノチド、塩酸ゲピロンER、PVT-011、その他)
・世界の女性用性的欲求低下障害(HSDD)治療薬市場:種類別市場規模予測 2021年-2026年(BP-101、ブレメラノチド、塩酸ゲピロンER、PVT-011、その他)
・世界の女性用性的欲求低下障害(HSDD)治療薬市場:用途別市場規模 2015年-2020年(外来患者、入院患者)
・世界の女性用性的欲求低下障害(HSDD)治療薬市場:用途別市場規模予測 2021年-2026年(外来患者、入院患者)
・北米の女性用性的欲求低下障害(HSDD)治療薬市場分析:米国、カナダ
・ヨーロッパの女性用性的欲求低下障害(HSDD)治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの女性用性的欲求低下障害(HSDD)治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の女性用性的欲求低下障害(HSDD)治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの女性用性的欲求低下障害(HSDD)治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Emotional Brain BV、GlaxoSmithKline Plc、Palatin Technologies Inc、Pivot Pharmaceuticals Inc、Strategic Science & Technologies LLC
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Female Hypoactive Sexual Desire Disorder Therapeutics Market
The global Female Hypoactive Sexual Desire Disorder Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Female Hypoactive Sexual Desire Disorder Therapeutics Scope and Market Size
Female Hypoactive Sexual Desire Disorder Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Female Hypoactive Sexual Desire Disorder Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Emotional Brain BV
GlaxoSmithKline Plc
Palatin Technologies Inc
Pivot Pharmaceuticals Inc
Strategic Science & Technologies LLC

Market segment by Type, the product can be split into
BP-101
Bremelanotide
Gepirone Hydrochloride ER
PVT-011
Others
Market segment by Application, split into
Out-Patient
In-Patient

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Female Hypoactive Sexual Desire Disorder Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 BP-101
1.4.3 Bremelanotide
1.4.4 Gepirone Hydrochloride ER
1.4.5 PVT-011
1.4.6 Others
1.5 Market by Application
1.5.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Out-Patient
1.5.3 In-Patient
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Perspective (2015-2026)
2.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Growth Trends by Regions
2.2.1 Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Female Hypoactive Sexual Desire Disorder Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Female Hypoactive Sexual Desire Disorder Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Female Hypoactive Sexual Desire Disorder Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Players by Market Size
3.1.1 Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Concentration Ratio
3.2.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Female Hypoactive Sexual Desire Disorder Therapeutics Revenue in 2019
3.3 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players Head office and Area Served
3.4 Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Product Solution and Service
3.5 Date of Enter into Female Hypoactive Sexual Desire Disorder Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020)
5.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2015-2020)
6.2 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players in North America (2019-2020)
6.3 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020)
6.4 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2015-2020)
7.2 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020)
7.4 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2015-2020)
8.2 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players in China (2019-2020)
8.3 China Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020)
8.4 China Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2015-2020)
9.2 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020)
9.4 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2015-2020)
10.2 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2015-2020)
11.2 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players in India (2019-2020)
11.3 India Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020)
11.4 India Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2015-2020)
12.2 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Emotional Brain BV
13.1.1 Emotional Brain BV Company Details
13.1.2 Emotional Brain BV Business Overview
13.1.3 Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
13.1.4 Emotional Brain BV Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2015-2020))
13.1.5 Emotional Brain BV Recent Development
13.2 GlaxoSmithKline Plc
13.2.1 GlaxoSmithKline Plc Company Details
13.2.2 GlaxoSmithKline Plc Business Overview
13.2.3 GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
13.2.4 GlaxoSmithKline Plc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2015-2020)
13.2.5 GlaxoSmithKline Plc Recent Development
13.3 Palatin Technologies Inc
13.3.1 Palatin Technologies Inc Company Details
13.3.2 Palatin Technologies Inc Business Overview
13.3.3 Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
13.3.4 Palatin Technologies Inc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2015-2020)
13.3.5 Palatin Technologies Inc Recent Development
13.4 Pivot Pharmaceuticals Inc
13.4.1 Pivot Pharmaceuticals Inc Company Details
13.4.2 Pivot Pharmaceuticals Inc Business Overview
13.4.3 Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
13.4.4 Pivot Pharmaceuticals Inc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2015-2020)
13.4.5 Pivot Pharmaceuticals Inc Recent Development
13.5 Strategic Science & Technologies LLC
13.5.1 Strategic Science & Technologies LLC Company Details
13.5.2 Strategic Science & Technologies LLC Business Overview
13.5.3 Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
13.5.4 Strategic Science & Technologies LLC Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2015-2020)
13.5.5 Strategic Science & Technologies LLC Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Emotional Brain BV、GlaxoSmithKline Plc、Palatin Technologies Inc、Pivot Pharmaceuticals Inc、Strategic Science & Technologies LLC

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の女性用性的欲求低下障害(HSDD)治療薬市場2026:インサイト・予測(Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。